AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimtoss 1mg/500mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Astonea Labs Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimtoss 1mg/500mg Tablet PR

Diabetace 1mg/500mg tablets are classified as antidiabetic medications, combining two agents to manage type 2 diabetes in adults. This formulation helps regulate blood sugar. Diabetace 1mg/500mg tablets should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood glucose response. Continued use is crucial, even with well-controlled blood sugar, as discontinuation without medical guidance risks elevated glucose levels and potential complications including kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as advised by your doctor. Lifestyle significantly impacts diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary snacks, fruit juice). Alcohol consumption elevates hypoglycemia risk and should be minimized. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glimtoss 1mg/500mg Tablet PR

Managing type 2 diabetes

Major Benefits of Glimtoss 1mg/500mg Tablet PR:

Follow your physician's instructions or consult the product label for dosage information. Administer Glimtoss 1mg/500mg Tablet PR with food.

Common Side effects of Glimtoss 1mg/500mg Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimtoss 1mg/500mg Tablet PR:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Administer Glimtoss 1mg/500mg Tablet PR with a meal.

How Glimtoss 1mg/500mg Tablet PR works:

Glimepiride/Metformin 1mg/500mg tablets (Glimtoss PR) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimtoss 1mg/500mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimtoss 1mg/500mg PR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimtoss 1mg/500mg Tablet PR are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimtoss 1mg/500mg Tablet PR cautiously, potentially requiring dosage modification. Consult your physician for guidance. Glimtoss 1mg/500mg Tablet PR is contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimtoss 1mg/500mg Tablet PR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Glimtoss 1mg/500mg Tablet PR therapy typically begins with a reduced dose; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimtoss 1mg/500mg Tablet PR :

Should you forget a Glimtoss 1mg/500mg PR tablet, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimtoss 1mg/500mg Tablet PR

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Glimtoss 1mg/500mg Tablet PR

Always keep this medication in its original, tightly sealed container. Follow the storage guidelines printed on the packaging. Discard any leftover medication. Ensure this medicine remains inaccessible to children, pets, and others.
Glimtoss 1mg/500mg Tablet PR can induce lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful adverse reaction is more prevalent in individuals with kidney impairment, the elderly, and those who consume significant alcohol. Symptoms may encompass muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms arise, discontinue Glimtoss 1mg/500mg Tablet PR and seek immediate medical attention.
The dual-component tablet, Glimtoss 1mg/500mg PR, comprises glimepiride and metformin, and is employed to manage type 2 diabetes mellitus in adults. Its efficacy in controlling blood sugar relies on adherence to a healthy diet and regular physical activity. Glimepiride functions by stimulating insulin secretion from the pancreas, thereby reducing blood glucose. Concurrently, metformin diminishes hepatic glucose production and enhances insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes mellitus.
Glimtoss 1mg/500mg Tablet PR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged administration may result in vitamin B12 deficiency.
Indeed, prolonged administration of Glimtoss 1mg/500mg Tablet PR can lead to Vitamin B12 deficiency. This medication hinders the body's absorption of Vitamin B12 within the gastrointestinal tract. Left unaddressed, this deficiency may result in anemia, neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental Vitamin B12 is recommended by some experts at least annually.
Indeed, Glimtoss 1mg/500mg tablets can induce hypoglycemia. Low blood sugar may manifest as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Glimtoss 1mg/500mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimtoss 1mg/500mg Tablet...
68
MRP 83
18% off